Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam · Delayed Price · Currency is VND 68,800
+1,000 (1.47%)
At close: Feb 24, 2026
Ha Tay Pharmaceutical JSC Revenue
In the year 2025, Ha Tay Pharmaceutical JSC had annual revenue of 2.40T VND with 15.13% growth. Ha Tay Pharmaceutical JSC had revenue of 692.88B in the quarter ending December 31, 2025, with 27.74% growth.
Revenue
2.40T
Revenue Growth
+15.13%
P/S Ratio
2.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.23T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.40T | 315.69B | 15.13% |
| Dec 31, 2024 | 2.09T | 87.05B | 4.35% |
| Jan 1, 2024 | 2.00T | 161.91B | 8.81% |
| Dec 31, 2022 | 1.84T | 228.03B | 14.17% |
| Dec 31, 2021 | 1.61T | -397.11B | -19.79% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DHG Pharmaceutical JSC | 4.98T |
| Traphaco JSC | 2.65T |
| Imexpharm | 2.44T |
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1.87T |
| Cuu Long Pharmaceutical JSC | 1.32T |
| OPC Pharmaceutical JSC | 1.12T |
| Vidipha Central Pharmaceutical JSC | 950.89B |